Regional Services - Medicare Mental Health Clinic in Springfield, MO

Regional Services is a medicare enrolled mental health clinic (Psychiatry & Neurology - Psychiatry) in Springfield, Missouri. The current practice location for Regional Services is 3801 S National Ave, Suite 900, Springfield, Missouri. For appointments, you can reach them via phone at (417) 269-2710. The mailing address for Regional Services is Po Box 505673, Saint Louis, Missouri and phone number is (417) 730-6430.

Regional Services is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1073905915. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (417) 269-2710.

Contact Information

Regional Services
3801 S National Ave
Suite 900
Springfield
MO 65807-5210
(417) 269-2710
(417) 269-3715

Mental Health Clinic Profile

Full NameRegional Services
SpecialityPsychiatry & Neurology
Location3801 S National Ave, Springfield, Missouri
Authorized Official Name and PositionBrock Shamel (VICE PRESIDENT)
Authorized Official Contact4172694368
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Regional Services
Po Box 505673
Saint Louis
MO 63150-5673

Ph: (417) 730-6430
Regional Services
3801 S National Ave
Suite 900
Springfield
MO 65807-5210

Ph: (417) 269-2710

NPI Details:

NPI Number1073905915
Provider Enumeration Date03/02/2015
Last Update Date04/16/2024
Certification Date04/16/2024

Medicare PECOS Information:

Medicare PECOS PAC ID5799787784
Medicare Enrollment IDO20150608002749

News Archive

Hutchison MediPharma achieves primary endpoint in POC Phase II study to treat NSCLC patients

Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, successfully achieved the primary endpoint in the second proof-of-concept ("POC") trial of fruquintinib in patients with advanced non-squamous non-small cell lung cancer ("NSCLC") in China.

Researchers show how metabolism drives proliferation of tumor cells

The metabolic state of tumor cells contributes to signals that control the proliferation of tumor cells. Already the German biochemist and Nobel Prize laureate Otto H. Warburg observed in the 1920s that tumor cells radically change their metabolism.

Bad gene associated with sudden death in epilepsy and breathing problems

In sudden death in epilepsy, people stop breathing for no apparent reason and die. Now, a group of UConn neuroscientists have a lead as to why, they report in the journal eLife.

Evidence suggests nearly 60% of people struggling with suicidal behavior do not receive any treatment

In this Review, published to coincide with the launch of The Lancet Psychiatry journal, Professor Rory O'Connor from the University of Glasgow and Professor Matthew K. Nock from Harvard University review the key psychological factors that may contribute to, or protect against, suicidal behaviour including personality differences, cognitive factors, and negative life events such as serious physical illness, as well as current psychological treatments.

Read more Medical News

› Verified 6 days ago

Medical Identifiers

Medical identifiers for Regional Services such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1073905915NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2084P0800XPsychiatry & Neurology - Psychiatry (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Regional Services acts as a billing entity for following providers:
Provider NameRex E Taber
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1144337403
PECOS PAC ID: 8527005198
Enrollment ID: I20050414000859

News Archive

Hutchison MediPharma achieves primary endpoint in POC Phase II study to treat NSCLC patients

Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, successfully achieved the primary endpoint in the second proof-of-concept ("POC") trial of fruquintinib in patients with advanced non-squamous non-small cell lung cancer ("NSCLC") in China.

Researchers show how metabolism drives proliferation of tumor cells

The metabolic state of tumor cells contributes to signals that control the proliferation of tumor cells. Already the German biochemist and Nobel Prize laureate Otto H. Warburg observed in the 1920s that tumor cells radically change their metabolism.

Bad gene associated with sudden death in epilepsy and breathing problems

In sudden death in epilepsy, people stop breathing for no apparent reason and die. Now, a group of UConn neuroscientists have a lead as to why, they report in the journal eLife.

Evidence suggests nearly 60% of people struggling with suicidal behavior do not receive any treatment

In this Review, published to coincide with the launch of The Lancet Psychiatry journal, Professor Rory O'Connor from the University of Glasgow and Professor Matthew K. Nock from Harvard University review the key psychological factors that may contribute to, or protect against, suicidal behaviour including personality differences, cognitive factors, and negative life events such as serious physical illness, as well as current psychological treatments.

Read more Medical News

› Verified 6 days ago

Provider NameKarla E Daniel
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1912072125
PECOS PAC ID: 4183643968
Enrollment ID: I20070105000080

News Archive

Hutchison MediPharma achieves primary endpoint in POC Phase II study to treat NSCLC patients

Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, successfully achieved the primary endpoint in the second proof-of-concept ("POC") trial of fruquintinib in patients with advanced non-squamous non-small cell lung cancer ("NSCLC") in China.

Researchers show how metabolism drives proliferation of tumor cells

The metabolic state of tumor cells contributes to signals that control the proliferation of tumor cells. Already the German biochemist and Nobel Prize laureate Otto H. Warburg observed in the 1920s that tumor cells radically change their metabolism.

Bad gene associated with sudden death in epilepsy and breathing problems

In sudden death in epilepsy, people stop breathing for no apparent reason and die. Now, a group of UConn neuroscientists have a lead as to why, they report in the journal eLife.

Evidence suggests nearly 60% of people struggling with suicidal behavior do not receive any treatment

In this Review, published to coincide with the launch of The Lancet Psychiatry journal, Professor Rory O'Connor from the University of Glasgow and Professor Matthew K. Nock from Harvard University review the key psychological factors that may contribute to, or protect against, suicidal behaviour including personality differences, cognitive factors, and negative life events such as serious physical illness, as well as current psychological treatments.

Read more Medical News

› Verified 6 days ago

Provider NameAdrian J Whitmire
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1083934228
PECOS PAC ID: 6103940135
Enrollment ID: I20100827000713

News Archive

Hutchison MediPharma achieves primary endpoint in POC Phase II study to treat NSCLC patients

Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, successfully achieved the primary endpoint in the second proof-of-concept ("POC") trial of fruquintinib in patients with advanced non-squamous non-small cell lung cancer ("NSCLC") in China.

Researchers show how metabolism drives proliferation of tumor cells

The metabolic state of tumor cells contributes to signals that control the proliferation of tumor cells. Already the German biochemist and Nobel Prize laureate Otto H. Warburg observed in the 1920s that tumor cells radically change their metabolism.

Bad gene associated with sudden death in epilepsy and breathing problems

In sudden death in epilepsy, people stop breathing for no apparent reason and die. Now, a group of UConn neuroscientists have a lead as to why, they report in the journal eLife.

Evidence suggests nearly 60% of people struggling with suicidal behavior do not receive any treatment

In this Review, published to coincide with the launch of The Lancet Psychiatry journal, Professor Rory O'Connor from the University of Glasgow and Professor Matthew K. Nock from Harvard University review the key psychological factors that may contribute to, or protect against, suicidal behaviour including personality differences, cognitive factors, and negative life events such as serious physical illness, as well as current psychological treatments.

Read more Medical News

› Verified 6 days ago

Provider NameEdgar Galinanes
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1134125081
PECOS PAC ID: 6002008398
Enrollment ID: I20101005000568

News Archive

Hutchison MediPharma achieves primary endpoint in POC Phase II study to treat NSCLC patients

Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, successfully achieved the primary endpoint in the second proof-of-concept ("POC") trial of fruquintinib in patients with advanced non-squamous non-small cell lung cancer ("NSCLC") in China.

Researchers show how metabolism drives proliferation of tumor cells

The metabolic state of tumor cells contributes to signals that control the proliferation of tumor cells. Already the German biochemist and Nobel Prize laureate Otto H. Warburg observed in the 1920s that tumor cells radically change their metabolism.

Bad gene associated with sudden death in epilepsy and breathing problems

In sudden death in epilepsy, people stop breathing for no apparent reason and die. Now, a group of UConn neuroscientists have a lead as to why, they report in the journal eLife.

Evidence suggests nearly 60% of people struggling with suicidal behavior do not receive any treatment

In this Review, published to coincide with the launch of The Lancet Psychiatry journal, Professor Rory O'Connor from the University of Glasgow and Professor Matthew K. Nock from Harvard University review the key psychological factors that may contribute to, or protect against, suicidal behaviour including personality differences, cognitive factors, and negative life events such as serious physical illness, as well as current psychological treatments.

Read more Medical News

› Verified 6 days ago

Provider NameGeorgina L Ashlock
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1194004192
PECOS PAC ID: 6204007560
Enrollment ID: I20110916000056

News Archive

Hutchison MediPharma achieves primary endpoint in POC Phase II study to treat NSCLC patients

Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, successfully achieved the primary endpoint in the second proof-of-concept ("POC") trial of fruquintinib in patients with advanced non-squamous non-small cell lung cancer ("NSCLC") in China.

Researchers show how metabolism drives proliferation of tumor cells

The metabolic state of tumor cells contributes to signals that control the proliferation of tumor cells. Already the German biochemist and Nobel Prize laureate Otto H. Warburg observed in the 1920s that tumor cells radically change their metabolism.

Bad gene associated with sudden death in epilepsy and breathing problems

In sudden death in epilepsy, people stop breathing for no apparent reason and die. Now, a group of UConn neuroscientists have a lead as to why, they report in the journal eLife.

Evidence suggests nearly 60% of people struggling with suicidal behavior do not receive any treatment

In this Review, published to coincide with the launch of The Lancet Psychiatry journal, Professor Rory O'Connor from the University of Glasgow and Professor Matthew K. Nock from Harvard University review the key psychological factors that may contribute to, or protect against, suicidal behaviour including personality differences, cognitive factors, and negative life events such as serious physical illness, as well as current psychological treatments.

Read more Medical News

› Verified 6 days ago

Provider NameThomas E Witty
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1356382824
PECOS PAC ID: 9234126327
Enrollment ID: I20120418000689

News Archive

Hutchison MediPharma achieves primary endpoint in POC Phase II study to treat NSCLC patients

Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, successfully achieved the primary endpoint in the second proof-of-concept ("POC") trial of fruquintinib in patients with advanced non-squamous non-small cell lung cancer ("NSCLC") in China.

Researchers show how metabolism drives proliferation of tumor cells

The metabolic state of tumor cells contributes to signals that control the proliferation of tumor cells. Already the German biochemist and Nobel Prize laureate Otto H. Warburg observed in the 1920s that tumor cells radically change their metabolism.

Bad gene associated with sudden death in epilepsy and breathing problems

In sudden death in epilepsy, people stop breathing for no apparent reason and die. Now, a group of UConn neuroscientists have a lead as to why, they report in the journal eLife.

Evidence suggests nearly 60% of people struggling with suicidal behavior do not receive any treatment

In this Review, published to coincide with the launch of The Lancet Psychiatry journal, Professor Rory O'Connor from the University of Glasgow and Professor Matthew K. Nock from Harvard University review the key psychological factors that may contribute to, or protect against, suicidal behaviour including personality differences, cognitive factors, and negative life events such as serious physical illness, as well as current psychological treatments.

Read more Medical News

› Verified 6 days ago

Provider NameNagib Chowdhury
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1184851792
PECOS PAC ID: 8325281207
Enrollment ID: I20130823001251

News Archive

Hutchison MediPharma achieves primary endpoint in POC Phase II study to treat NSCLC patients

Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, successfully achieved the primary endpoint in the second proof-of-concept ("POC") trial of fruquintinib in patients with advanced non-squamous non-small cell lung cancer ("NSCLC") in China.

Researchers show how metabolism drives proliferation of tumor cells

The metabolic state of tumor cells contributes to signals that control the proliferation of tumor cells. Already the German biochemist and Nobel Prize laureate Otto H. Warburg observed in the 1920s that tumor cells radically change their metabolism.

Bad gene associated with sudden death in epilepsy and breathing problems

In sudden death in epilepsy, people stop breathing for no apparent reason and die. Now, a group of UConn neuroscientists have a lead as to why, they report in the journal eLife.

Evidence suggests nearly 60% of people struggling with suicidal behavior do not receive any treatment

In this Review, published to coincide with the launch of The Lancet Psychiatry journal, Professor Rory O'Connor from the University of Glasgow and Professor Matthew K. Nock from Harvard University review the key psychological factors that may contribute to, or protect against, suicidal behaviour including personality differences, cognitive factors, and negative life events such as serious physical illness, as well as current psychological treatments.

Read more Medical News

› Verified 6 days ago

Provider NameChristi M Nothnagel
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1235501594
PECOS PAC ID: 4385932771
Enrollment ID: I20161018002440

News Archive

Hutchison MediPharma achieves primary endpoint in POC Phase II study to treat NSCLC patients

Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, successfully achieved the primary endpoint in the second proof-of-concept ("POC") trial of fruquintinib in patients with advanced non-squamous non-small cell lung cancer ("NSCLC") in China.

Researchers show how metabolism drives proliferation of tumor cells

The metabolic state of tumor cells contributes to signals that control the proliferation of tumor cells. Already the German biochemist and Nobel Prize laureate Otto H. Warburg observed in the 1920s that tumor cells radically change their metabolism.

Bad gene associated with sudden death in epilepsy and breathing problems

In sudden death in epilepsy, people stop breathing for no apparent reason and die. Now, a group of UConn neuroscientists have a lead as to why, they report in the journal eLife.

Evidence suggests nearly 60% of people struggling with suicidal behavior do not receive any treatment

In this Review, published to coincide with the launch of The Lancet Psychiatry journal, Professor Rory O'Connor from the University of Glasgow and Professor Matthew K. Nock from Harvard University review the key psychological factors that may contribute to, or protect against, suicidal behaviour including personality differences, cognitive factors, and negative life events such as serious physical illness, as well as current psychological treatments.

Read more Medical News

› Verified 6 days ago

Provider NameVincen Gene Barnes
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1093870875
PECOS PAC ID: 5294814893
Enrollment ID: I20190114002966

News Archive

Hutchison MediPharma achieves primary endpoint in POC Phase II study to treat NSCLC patients

Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, successfully achieved the primary endpoint in the second proof-of-concept ("POC") trial of fruquintinib in patients with advanced non-squamous non-small cell lung cancer ("NSCLC") in China.

Researchers show how metabolism drives proliferation of tumor cells

The metabolic state of tumor cells contributes to signals that control the proliferation of tumor cells. Already the German biochemist and Nobel Prize laureate Otto H. Warburg observed in the 1920s that tumor cells radically change their metabolism.

Bad gene associated with sudden death in epilepsy and breathing problems

In sudden death in epilepsy, people stop breathing for no apparent reason and die. Now, a group of UConn neuroscientists have a lead as to why, they report in the journal eLife.

Evidence suggests nearly 60% of people struggling with suicidal behavior do not receive any treatment

In this Review, published to coincide with the launch of The Lancet Psychiatry journal, Professor Rory O'Connor from the University of Glasgow and Professor Matthew K. Nock from Harvard University review the key psychological factors that may contribute to, or protect against, suicidal behaviour including personality differences, cognitive factors, and negative life events such as serious physical illness, as well as current psychological treatments.

Read more Medical News

› Verified 6 days ago

Provider NameKylie Kristen Pottenger
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1902219355
PECOS PAC ID: 1658605738
Enrollment ID: I20190624001568

News Archive

Hutchison MediPharma achieves primary endpoint in POC Phase II study to treat NSCLC patients

Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, successfully achieved the primary endpoint in the second proof-of-concept ("POC") trial of fruquintinib in patients with advanced non-squamous non-small cell lung cancer ("NSCLC") in China.

Researchers show how metabolism drives proliferation of tumor cells

The metabolic state of tumor cells contributes to signals that control the proliferation of tumor cells. Already the German biochemist and Nobel Prize laureate Otto H. Warburg observed in the 1920s that tumor cells radically change their metabolism.

Bad gene associated with sudden death in epilepsy and breathing problems

In sudden death in epilepsy, people stop breathing for no apparent reason and die. Now, a group of UConn neuroscientists have a lead as to why, they report in the journal eLife.

Evidence suggests nearly 60% of people struggling with suicidal behavior do not receive any treatment

In this Review, published to coincide with the launch of The Lancet Psychiatry journal, Professor Rory O'Connor from the University of Glasgow and Professor Matthew K. Nock from Harvard University review the key psychological factors that may contribute to, or protect against, suicidal behaviour including personality differences, cognitive factors, and negative life events such as serious physical illness, as well as current psychological treatments.

Read more Medical News

› Verified 6 days ago

Provider NameElizabeth Scott
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1306990064
PECOS PAC ID: 3072915743
Enrollment ID: I20210719000464

News Archive

Hutchison MediPharma achieves primary endpoint in POC Phase II study to treat NSCLC patients

Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, successfully achieved the primary endpoint in the second proof-of-concept ("POC") trial of fruquintinib in patients with advanced non-squamous non-small cell lung cancer ("NSCLC") in China.

Researchers show how metabolism drives proliferation of tumor cells

The metabolic state of tumor cells contributes to signals that control the proliferation of tumor cells. Already the German biochemist and Nobel Prize laureate Otto H. Warburg observed in the 1920s that tumor cells radically change their metabolism.

Bad gene associated with sudden death in epilepsy and breathing problems

In sudden death in epilepsy, people stop breathing for no apparent reason and die. Now, a group of UConn neuroscientists have a lead as to why, they report in the journal eLife.

Evidence suggests nearly 60% of people struggling with suicidal behavior do not receive any treatment

In this Review, published to coincide with the launch of The Lancet Psychiatry journal, Professor Rory O'Connor from the University of Glasgow and Professor Matthew K. Nock from Harvard University review the key psychological factors that may contribute to, or protect against, suicidal behaviour including personality differences, cognitive factors, and negative life events such as serious physical illness, as well as current psychological treatments.

Read more Medical News

› Verified 6 days ago

Provider NameSamantha Janvier
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1124745898
PECOS PAC ID: 1658741186
Enrollment ID: I20221228000617

News Archive

Hutchison MediPharma achieves primary endpoint in POC Phase II study to treat NSCLC patients

Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, successfully achieved the primary endpoint in the second proof-of-concept ("POC") trial of fruquintinib in patients with advanced non-squamous non-small cell lung cancer ("NSCLC") in China.

Researchers show how metabolism drives proliferation of tumor cells

The metabolic state of tumor cells contributes to signals that control the proliferation of tumor cells. Already the German biochemist and Nobel Prize laureate Otto H. Warburg observed in the 1920s that tumor cells radically change their metabolism.

Bad gene associated with sudden death in epilepsy and breathing problems

In sudden death in epilepsy, people stop breathing for no apparent reason and die. Now, a group of UConn neuroscientists have a lead as to why, they report in the journal eLife.

Evidence suggests nearly 60% of people struggling with suicidal behavior do not receive any treatment

In this Review, published to coincide with the launch of The Lancet Psychiatry journal, Professor Rory O'Connor from the University of Glasgow and Professor Matthew K. Nock from Harvard University review the key psychological factors that may contribute to, or protect against, suicidal behaviour including personality differences, cognitive factors, and negative life events such as serious physical illness, as well as current psychological treatments.

Read more Medical News

› Verified 6 days ago

Provider NameBralin Lee Barnes
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1154081461
PECOS PAC ID: 5698145548
Enrollment ID: I20230110002342

News Archive

Hutchison MediPharma achieves primary endpoint in POC Phase II study to treat NSCLC patients

Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, successfully achieved the primary endpoint in the second proof-of-concept ("POC") trial of fruquintinib in patients with advanced non-squamous non-small cell lung cancer ("NSCLC") in China.

Researchers show how metabolism drives proliferation of tumor cells

The metabolic state of tumor cells contributes to signals that control the proliferation of tumor cells. Already the German biochemist and Nobel Prize laureate Otto H. Warburg observed in the 1920s that tumor cells radically change their metabolism.

Bad gene associated with sudden death in epilepsy and breathing problems

In sudden death in epilepsy, people stop breathing for no apparent reason and die. Now, a group of UConn neuroscientists have a lead as to why, they report in the journal eLife.

Evidence suggests nearly 60% of people struggling with suicidal behavior do not receive any treatment

In this Review, published to coincide with the launch of The Lancet Psychiatry journal, Professor Rory O'Connor from the University of Glasgow and Professor Matthew K. Nock from Harvard University review the key psychological factors that may contribute to, or protect against, suicidal behaviour including personality differences, cognitive factors, and negative life events such as serious physical illness, as well as current psychological treatments.

Read more Medical News

› Verified 6 days ago

Provider NameKatharine Meese Putman
Provider TypePractitioner - Psychologist Billing Independently
Provider IdentifiersNPI Number: 1265975197
PECOS PAC ID: 0244686624
Enrollment ID: I20231020000903

News Archive

Hutchison MediPharma achieves primary endpoint in POC Phase II study to treat NSCLC patients

Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, successfully achieved the primary endpoint in the second proof-of-concept ("POC") trial of fruquintinib in patients with advanced non-squamous non-small cell lung cancer ("NSCLC") in China.

Researchers show how metabolism drives proliferation of tumor cells

The metabolic state of tumor cells contributes to signals that control the proliferation of tumor cells. Already the German biochemist and Nobel Prize laureate Otto H. Warburg observed in the 1920s that tumor cells radically change their metabolism.

Bad gene associated with sudden death in epilepsy and breathing problems

In sudden death in epilepsy, people stop breathing for no apparent reason and die. Now, a group of UConn neuroscientists have a lead as to why, they report in the journal eLife.

Evidence suggests nearly 60% of people struggling with suicidal behavior do not receive any treatment

In this Review, published to coincide with the launch of The Lancet Psychiatry journal, Professor Rory O'Connor from the University of Glasgow and Professor Matthew K. Nock from Harvard University review the key psychological factors that may contribute to, or protect against, suicidal behaviour including personality differences, cognitive factors, and negative life events such as serious physical illness, as well as current psychological treatments.

Read more Medical News

› Verified 6 days ago

Provider NameMckenzie Nickerson
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1043807456
PECOS PAC ID: 0446600977
Enrollment ID: I20231227000239

News Archive

Hutchison MediPharma achieves primary endpoint in POC Phase II study to treat NSCLC patients

Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, successfully achieved the primary endpoint in the second proof-of-concept ("POC") trial of fruquintinib in patients with advanced non-squamous non-small cell lung cancer ("NSCLC") in China.

Researchers show how metabolism drives proliferation of tumor cells

The metabolic state of tumor cells contributes to signals that control the proliferation of tumor cells. Already the German biochemist and Nobel Prize laureate Otto H. Warburg observed in the 1920s that tumor cells radically change their metabolism.

Bad gene associated with sudden death in epilepsy and breathing problems

In sudden death in epilepsy, people stop breathing for no apparent reason and die. Now, a group of UConn neuroscientists have a lead as to why, they report in the journal eLife.

Evidence suggests nearly 60% of people struggling with suicidal behavior do not receive any treatment

In this Review, published to coincide with the launch of The Lancet Psychiatry journal, Professor Rory O'Connor from the University of Glasgow and Professor Matthew K. Nock from Harvard University review the key psychological factors that may contribute to, or protect against, suicidal behaviour including personality differences, cognitive factors, and negative life events such as serious physical illness, as well as current psychological treatments.

Read more Medical News

› Verified 6 days ago

Provider NamePaulette A Harvey
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1699201558
PECOS PAC ID: 9234589771
Enrollment ID: I20231227000337

News Archive

Hutchison MediPharma achieves primary endpoint in POC Phase II study to treat NSCLC patients

Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, successfully achieved the primary endpoint in the second proof-of-concept ("POC") trial of fruquintinib in patients with advanced non-squamous non-small cell lung cancer ("NSCLC") in China.

Researchers show how metabolism drives proliferation of tumor cells

The metabolic state of tumor cells contributes to signals that control the proliferation of tumor cells. Already the German biochemist and Nobel Prize laureate Otto H. Warburg observed in the 1920s that tumor cells radically change their metabolism.

Bad gene associated with sudden death in epilepsy and breathing problems

In sudden death in epilepsy, people stop breathing for no apparent reason and die. Now, a group of UConn neuroscientists have a lead as to why, they report in the journal eLife.

Evidence suggests nearly 60% of people struggling with suicidal behavior do not receive any treatment

In this Review, published to coincide with the launch of The Lancet Psychiatry journal, Professor Rory O'Connor from the University of Glasgow and Professor Matthew K. Nock from Harvard University review the key psychological factors that may contribute to, or protect against, suicidal behaviour including personality differences, cognitive factors, and negative life events such as serious physical illness, as well as current psychological treatments.

Read more Medical News

› Verified 6 days ago

Provider NameRebecca Ann Dalton
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1285126235
PECOS PAC ID: 7315397759
Enrollment ID: I20231227000725

News Archive

Hutchison MediPharma achieves primary endpoint in POC Phase II study to treat NSCLC patients

Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, successfully achieved the primary endpoint in the second proof-of-concept ("POC") trial of fruquintinib in patients with advanced non-squamous non-small cell lung cancer ("NSCLC") in China.

Researchers show how metabolism drives proliferation of tumor cells

The metabolic state of tumor cells contributes to signals that control the proliferation of tumor cells. Already the German biochemist and Nobel Prize laureate Otto H. Warburg observed in the 1920s that tumor cells radically change their metabolism.

Bad gene associated with sudden death in epilepsy and breathing problems

In sudden death in epilepsy, people stop breathing for no apparent reason and die. Now, a group of UConn neuroscientists have a lead as to why, they report in the journal eLife.

Evidence suggests nearly 60% of people struggling with suicidal behavior do not receive any treatment

In this Review, published to coincide with the launch of The Lancet Psychiatry journal, Professor Rory O'Connor from the University of Glasgow and Professor Matthew K. Nock from Harvard University review the key psychological factors that may contribute to, or protect against, suicidal behaviour including personality differences, cognitive factors, and negative life events such as serious physical illness, as well as current psychological treatments.

Read more Medical News

› Verified 6 days ago

Provider NameCameo Hopper
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1508300435
PECOS PAC ID: 6507216983
Enrollment ID: I20231227002305

News Archive

Hutchison MediPharma achieves primary endpoint in POC Phase II study to treat NSCLC patients

Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, successfully achieved the primary endpoint in the second proof-of-concept ("POC") trial of fruquintinib in patients with advanced non-squamous non-small cell lung cancer ("NSCLC") in China.

Researchers show how metabolism drives proliferation of tumor cells

The metabolic state of tumor cells contributes to signals that control the proliferation of tumor cells. Already the German biochemist and Nobel Prize laureate Otto H. Warburg observed in the 1920s that tumor cells radically change their metabolism.

Bad gene associated with sudden death in epilepsy and breathing problems

In sudden death in epilepsy, people stop breathing for no apparent reason and die. Now, a group of UConn neuroscientists have a lead as to why, they report in the journal eLife.

Evidence suggests nearly 60% of people struggling with suicidal behavior do not receive any treatment

In this Review, published to coincide with the launch of The Lancet Psychiatry journal, Professor Rory O'Connor from the University of Glasgow and Professor Matthew K. Nock from Harvard University review the key psychological factors that may contribute to, or protect against, suicidal behaviour including personality differences, cognitive factors, and negative life events such as serious physical illness, as well as current psychological treatments.

Read more Medical News

› Verified 6 days ago

Provider NameSue Ann Brown
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1144356155
PECOS PAC ID: 4880044825
Enrollment ID: I20240103001262

News Archive

Hutchison MediPharma achieves primary endpoint in POC Phase II study to treat NSCLC patients

Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, successfully achieved the primary endpoint in the second proof-of-concept ("POC") trial of fruquintinib in patients with advanced non-squamous non-small cell lung cancer ("NSCLC") in China.

Researchers show how metabolism drives proliferation of tumor cells

The metabolic state of tumor cells contributes to signals that control the proliferation of tumor cells. Already the German biochemist and Nobel Prize laureate Otto H. Warburg observed in the 1920s that tumor cells radically change their metabolism.

Bad gene associated with sudden death in epilepsy and breathing problems

In sudden death in epilepsy, people stop breathing for no apparent reason and die. Now, a group of UConn neuroscientists have a lead as to why, they report in the journal eLife.

Evidence suggests nearly 60% of people struggling with suicidal behavior do not receive any treatment

In this Review, published to coincide with the launch of The Lancet Psychiatry journal, Professor Rory O'Connor from the University of Glasgow and Professor Matthew K. Nock from Harvard University review the key psychological factors that may contribute to, or protect against, suicidal behaviour including personality differences, cognitive factors, and negative life events such as serious physical illness, as well as current psychological treatments.

Read more Medical News

› Verified 6 days ago

Provider NameArin M Brutlag
Provider TypePractitioner - Marriage And Family Therapist
Provider IdentifiersNPI Number: 1215553862
PECOS PAC ID: 7911359369
Enrollment ID: I20240122001287

News Archive

Hutchison MediPharma achieves primary endpoint in POC Phase II study to treat NSCLC patients

Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, successfully achieved the primary endpoint in the second proof-of-concept ("POC") trial of fruquintinib in patients with advanced non-squamous non-small cell lung cancer ("NSCLC") in China.

Researchers show how metabolism drives proliferation of tumor cells

The metabolic state of tumor cells contributes to signals that control the proliferation of tumor cells. Already the German biochemist and Nobel Prize laureate Otto H. Warburg observed in the 1920s that tumor cells radically change their metabolism.

Bad gene associated with sudden death in epilepsy and breathing problems

In sudden death in epilepsy, people stop breathing for no apparent reason and die. Now, a group of UConn neuroscientists have a lead as to why, they report in the journal eLife.

Evidence suggests nearly 60% of people struggling with suicidal behavior do not receive any treatment

In this Review, published to coincide with the launch of The Lancet Psychiatry journal, Professor Rory O'Connor from the University of Glasgow and Professor Matthew K. Nock from Harvard University review the key psychological factors that may contribute to, or protect against, suicidal behaviour including personality differences, cognitive factors, and negative life events such as serious physical illness, as well as current psychological treatments.

Read more Medical News

› Verified 6 days ago

Provider NameMargaret Gertrude Werner
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1023322278
PECOS PAC ID: 8022453174
Enrollment ID: I20240228001632

News Archive

Hutchison MediPharma achieves primary endpoint in POC Phase II study to treat NSCLC patients

Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, successfully achieved the primary endpoint in the second proof-of-concept ("POC") trial of fruquintinib in patients with advanced non-squamous non-small cell lung cancer ("NSCLC") in China.

Researchers show how metabolism drives proliferation of tumor cells

The metabolic state of tumor cells contributes to signals that control the proliferation of tumor cells. Already the German biochemist and Nobel Prize laureate Otto H. Warburg observed in the 1920s that tumor cells radically change their metabolism.

Bad gene associated with sudden death in epilepsy and breathing problems

In sudden death in epilepsy, people stop breathing for no apparent reason and die. Now, a group of UConn neuroscientists have a lead as to why, they report in the journal eLife.

Evidence suggests nearly 60% of people struggling with suicidal behavior do not receive any treatment

In this Review, published to coincide with the launch of The Lancet Psychiatry journal, Professor Rory O'Connor from the University of Glasgow and Professor Matthew K. Nock from Harvard University review the key psychological factors that may contribute to, or protect against, suicidal behaviour including personality differences, cognitive factors, and negative life events such as serious physical illness, as well as current psychological treatments.

Read more Medical News

› Verified 6 days ago

News Archive

Hutchison MediPharma achieves primary endpoint in POC Phase II study to treat NSCLC patients

Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, successfully achieved the primary endpoint in the second proof-of-concept ("POC") trial of fruquintinib in patients with advanced non-squamous non-small cell lung cancer ("NSCLC") in China.

Researchers show how metabolism drives proliferation of tumor cells

The metabolic state of tumor cells contributes to signals that control the proliferation of tumor cells. Already the German biochemist and Nobel Prize laureate Otto H. Warburg observed in the 1920s that tumor cells radically change their metabolism.

Bad gene associated with sudden death in epilepsy and breathing problems

In sudden death in epilepsy, people stop breathing for no apparent reason and die. Now, a group of UConn neuroscientists have a lead as to why, they report in the journal eLife.

Evidence suggests nearly 60% of people struggling with suicidal behavior do not receive any treatment

In this Review, published to coincide with the launch of The Lancet Psychiatry journal, Professor Rory O'Connor from the University of Glasgow and Professor Matthew K. Nock from Harvard University review the key psychological factors that may contribute to, or protect against, suicidal behaviour including personality differences, cognitive factors, and negative life events such as serious physical illness, as well as current psychological treatments.

Read more News

› Verified 6 days ago

Psychiatry & Neurology in Springfield, MO

Breaking The Mental Chains, Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1522 E Camino Alto St, Springfield, MO 65804
Phone: 417-894-2731    Fax: 417-890-7757
Springfield Psychological Services
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 3863a S Campbell Ave, Springfield, MO 65807
Phone: 417-882-2211    
Life Counseling Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 2135 S Eastgate Ave, Springfield, MO 65809
Phone: 417-221-6252    
Murrell Counseling Service
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1358 E Kingsley St Ste B, Springfield, MO 65804
Phone: 417-881-1580    Fax: 417-881-7004
Krm Counseling And Consulting
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1101 S Broadway Ave, Springfield, MO 65807
Phone: 417-838-9461    
Integrative Family Psychology
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1340 E Meadowmere St, Springfield, MO 65804
Phone: 417-848-9054    
Preferred Family Healthcare Inc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1111 S Glenstone Ave, Springfield, MO 65804
Phone: 417-869-8911    Fax: 417-864-3087

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.